Logo image of PATH

UIPATH INC - CLASS A (PATH) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:PATH - US90364P1057 - Common Stock

16.84 USD
-0.32 (-1.86%)
Last: 12/26/2025, 8:09:08 PM
16.55 USD
-0.29 (-1.72%)
Pre-Market: 12/29/2025, 4:50:12 AM
Fundamental Rating

6

PATH gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 276 industry peers in the Software industry. PATH is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. PATH is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make PATH suitable for growth investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

PATH had positive earnings in the past year.
In the past year PATH had a positive cash flow from operations.
PATH had negative earnings in each of the past 5 years.
In multiple years PATH reported negative operating cash flow during the last 5 years.
PATH Yearly Net Income VS EBIT VS OCF VS FCFPATH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M

1.2 Ratios

PATH has a Return On Assets of 7.93%. This is amongst the best in the industry. PATH outperforms 80.07% of its industry peers.
PATH's Return On Equity of 11.93% is fine compared to the rest of the industry. PATH outperforms 75.36% of its industry peers.
With a decent Return On Invested Capital value of 0.88%, PATH is doing good in the industry, outperforming 61.96% of the companies in the same industry.
Industry RankSector Rank
ROA 7.93%
ROE 11.93%
ROIC 0.88%
ROA(3y)-5.87%
ROA(5y)-9.74%
ROE(3y)-8.52%
ROE(5y)-15%
ROIC(3y)N/A
ROIC(5y)N/A
PATH Yearly ROA, ROE, ROICPATH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150 -200 -250

1.3 Margins

PATH has a Profit Margin of 14.79%. This is in the better half of the industry: PATH outperforms 77.54% of its industry peers.
Looking at the Operating Margin, with a value of 1.52%, PATH is in the better half of the industry, outperforming 61.96% of the companies in the same industry.
PATH has a better Gross Margin (83.35%) than 89.49% of its industry peers.
PATH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.52%
PM (TTM) 14.79%
GM 83.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y0.08%
PATH Yearly Profit, Operating, Gross MarginsPATH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

8

2. Health

2.1 Basic Checks

PATH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for PATH has been reduced compared to 1 year ago.
PATH has more shares outstanding than it did 5 years ago.
There is no outstanding debt for PATH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PATH Yearly Shares OutstandingPATH Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
PATH Yearly Total Debt VS Total AssetsPATH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

PATH has an Altman-Z score of 5.75. This indicates that PATH is financially healthy and has little risk of bankruptcy at the moment.
PATH's Altman-Z score of 5.75 is fine compared to the rest of the industry. PATH outperforms 74.28% of its industry peers.
PATH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.75
ROIC/WACC0.08
WACC11%
PATH Yearly LT Debt VS Equity VS FCFPATH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

PATH has a Current Ratio of 2.65. This indicates that PATH is financially healthy and has no problem in meeting its short term obligations.
PATH has a Current ratio of 2.65. This is in the better half of the industry: PATH outperforms 71.38% of its industry peers.
PATH has a Quick Ratio of 2.65. This indicates that PATH is financially healthy and has no problem in meeting its short term obligations.
PATH's Quick ratio of 2.65 is fine compared to the rest of the industry. PATH outperforms 71.74% of its industry peers.
Industry RankSector Rank
Current Ratio 2.65
Quick Ratio 2.65
PATH Yearly Current Assets VS Current LiabilitesPATH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

7

3. Growth

3.1 Past

PATH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.00%, which is quite impressive.
Measured over the past years, PATH shows a very strong growth in Earnings Per Share. The EPS has been growing by 88.99% on average per year.
Looking at the last year, PATH shows a quite strong growth in Revenue. The Revenue has grown by 10.05% in the last year.
Measured over the past years, PATH shows a very strong growth in Revenue. The Revenue has been growing by 33.58% on average per year.
EPS 1Y (TTM)36%
EPS 3Y88.99%
EPS 5YN/A
EPS Q2Q%45.45%
Revenue 1Y (TTM)10.05%
Revenue growth 3Y17.01%
Revenue growth 5Y33.58%
Sales Q2Q%15.92%

3.2 Future

PATH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.84% yearly.
The Revenue is expected to grow by 11.61% on average over the next years. This is quite good.
EPS Next Y26.57%
EPS Next 2Y19.6%
EPS Next 3Y15.7%
EPS Next 5Y1.84%
Revenue Next Year11.23%
Revenue Next 2Y10.42%
Revenue Next 3Y9.84%
Revenue Next 5Y11.61%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PATH Yearly Revenue VS EstimatesPATH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B 2B 2.5B
PATH Yearly EPS VS EstimatesPATH Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0.2 0.4 0.6 0.8

4

4. Valuation

4.1 Price/Earnings Ratio

PATH is valuated rather expensively with a Price/Earnings ratio of 24.76.
68.48% of the companies in the same industry are more expensive than PATH, based on the Price/Earnings ratio.
PATH's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.92.
The Price/Forward Earnings ratio is 21.80, which indicates a rather expensive current valuation of PATH.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PATH indicates a somewhat cheap valuation: PATH is cheaper than 71.01% of the companies listed in the same industry.
PATH's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.46.
Industry RankSector Rank
PE 24.76
Fwd PE 21.8
PATH Price Earnings VS Forward Price EarningsPATH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

PATH's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, PATH is valued a bit cheaper than the industry average as 71.74% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 28.7
EV/EBITDA 177.68
PATH Per share dataPATH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PATH's earnings are expected to grow with 15.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.93
PEG (5Y)N/A
EPS Next 2Y19.6%
EPS Next 3Y15.7%

0

5. Dividend

5.1 Amount

PATH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

UIPATH INC - CLASS A

NYSE:PATH (12/26/2025, 8:09:08 PM)

Premarket: 16.55 -0.29 (-1.72%)

16.84

-0.32 (-1.86%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-03 2025-12-03/amc
Earnings (Next)03-10 2026-03-10/amc
Inst Owners71.21%
Inst Owner Change-22.14%
Ins Owners8.08%
Ins Owner Change3.47%
Market Cap8.94B
Revenue(TTM)1.55B
Net Income(TTM)229.66M
Analysts67.14
Price Target16.43 (-2.43%)
Short Float %11.66%
Short Ratio1.79
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)45.54%
Min EPS beat(2)7.4%
Max EPS beat(2)83.69%
EPS beat(4)4
Avg EPS beat(4)31.39%
Min EPS beat(4)7.36%
Max EPS beat(4)83.69%
EPS beat(8)8
Avg EPS beat(8)29.9%
EPS beat(12)12
Avg EPS beat(12)80.56%
EPS beat(16)16
Avg EPS beat(16)90.76%
Revenue beat(2)2
Avg Revenue beat(2)2.34%
Min Revenue beat(2)2.11%
Max Revenue beat(2)2.57%
Revenue beat(4)3
Avg Revenue beat(4)1.84%
Min Revenue beat(4)-2.36%
Max Revenue beat(4)5.03%
Revenue beat(8)6
Avg Revenue beat(8)1.45%
Revenue beat(12)9
Avg Revenue beat(12)2.16%
Revenue beat(16)13
Avg Revenue beat(16)2.46%
PT rev (1m)19.07%
PT rev (3m)22.76%
EPS NQ rev (1m)-2.12%
EPS NQ rev (3m)1.08%
EPS NY rev (1m)1.37%
EPS NY rev (3m)1.96%
Revenue NQ rev (1m)0.29%
Revenue NQ rev (3m)-0.35%
Revenue NY rev (1m)1.18%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 24.76
Fwd PE 21.8
P/S 5.76
P/FCF 28.7
P/OCF 26.7
P/B 4.65
P/tB 5.02
EV/EBITDA 177.68
EPS(TTM)0.68
EY4.04%
EPS(NY)0.77
Fwd EY4.59%
FCF(TTM)0.59
FCFY3.48%
OCF(TTM)0.63
OCFY3.75%
SpS2.92
BVpS3.62
TBVpS3.36
PEG (NY)0.93
PEG (5Y)N/A
Graham Number7.45
Profitability
Industry RankSector Rank
ROA 7.93%
ROE 11.93%
ROCE 1.12%
ROIC 0.88%
ROICexc 2.63%
ROICexgc 3.28%
OM 1.52%
PM (TTM) 14.79%
GM 83.35%
FCFM 20.06%
ROA(3y)-5.87%
ROA(5y)-9.74%
ROE(3y)-8.52%
ROE(5y)-15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y0.08%
F-Score8
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 153.76%
Cap/Sales 1.51%
Interest Coverage 250
Cash Conversion 863.81%
Profit Quality 135.66%
Current Ratio 2.65
Quick Ratio 2.65
Altman-Z 5.75
F-Score8
WACC11%
ROIC/WACC0.08
Cap/Depr(3y)82.11%
Cap/Depr(5y)72.19%
Cap/Sales(3y)1.29%
Cap/Sales(5y)1.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36%
EPS 3Y88.99%
EPS 5YN/A
EPS Q2Q%45.45%
EPS Next Y26.57%
EPS Next 2Y19.6%
EPS Next 3Y15.7%
EPS Next 5Y1.84%
Revenue 1Y (TTM)10.05%
Revenue growth 3Y17.01%
Revenue growth 5Y33.58%
Sales Q2Q%15.92%
Revenue Next Year11.23%
Revenue Next 2Y10.42%
Revenue Next 3Y9.84%
Revenue Next 5Y11.61%
EBIT growth 1Y114.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year81.12%
EBIT Next 3Y32.64%
EBIT Next 5Y22.63%
FCF growth 1Y28.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.4%
OCF growth 3YN/A
OCF growth 5YN/A

UIPATH INC - CLASS A / PATH FAQ

What is the fundamental rating for PATH stock?

ChartMill assigns a fundamental rating of 6 / 10 to PATH.


Can you provide the valuation status for UIPATH INC - CLASS A?

ChartMill assigns a valuation rating of 4 / 10 to UIPATH INC - CLASS A (PATH). This can be considered as Fairly Valued.


How profitable is UIPATH INC - CLASS A (PATH) stock?

UIPATH INC - CLASS A (PATH) has a profitability rating of 4 / 10.


How financially healthy is UIPATH INC - CLASS A?

The financial health rating of UIPATH INC - CLASS A (PATH) is 8 / 10.